Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • End-of-life conversations aren't just about health care

  • Connection between human translation and computerized translation programs

  • Increased levels of the body's own cannabinoids impair embryonic brain development

  • New research links bad diet to loss of smell

  • 'Moral victories' might spare you from losing again

  • Enzyme linked to Alzheimer?s disease

  • Try, try again? Study says no: Trying harder makes it more difficult to learn some aspects of language, neuroscientists find

  • Epigenetic tie to neuropsychiatric disorders found

  • Preeclampsia May Share Cause with Disorders Such as Alzheimer's

  • Depression during a mother?s postpartum year linked to homelessness risk

  •